Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-137412)

Filing Details

Accession Number:: 0001104659-20-137412
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-18 16:05:26
Reporting Period:: 2020-12-16

Accepted Time:: 2020-12-18 16:05:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
895051	Casi Pharmaceuticals Inc.	CASI	Biological Products, (No Disgnostic Substances) (2836)	581959440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835368	Weihao Xu	C/O Casi Pharmaceuticals, Inc. 9620 Medical Center Drive, Suite 300 Rockville MD 20850	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-16	2,000	$2.44	6,000	No	4	P	Indirect	Held by spouse
Common Stock	Acquisiton	2020-12-17	1,721	$2.64	7,721	No	4	P	Indirect	Held by spouse
Common Stock	Acquisiton	2020-12-17	2,279	$2.63	10,000	No	4	P	Indirect	Held by spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by spouse
No	4	P	Indirect	Held by spouse
No	4	P	Indirect	Held by spouse

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2020-12-16	800,000	$0.00	800,000	$2.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
800,000		2030-12-16	No	4	A	Direct

Footnotes

The stock options vest as follows: 160,000 options on each of the first and second anniversaries of the date of grant and 240,000 options on each of the third and fourth anniversaries of the date of grant.